Is it time to update your workplace drug testing policy for THC?
While this article from MENSXP specifically addresses actions by California employers, the suggestions can and should be taken by all employers when it comes to dealing with drug testing for THC in the workplace. This is a summary of the article. We encourage you to read the article in its entirety.
For years, when employers tested for THC the standard answer was simple: order a basic multi-panel urine test that included marijuana and treat a positive result as a straightforward policy violation. That model no longer fits the current legal and cultural landscape. Today, employers are expected to distinguish between off-duty, lawful cannabis use and on-the-job impairment, and that expectation runs straight through the heart of any credible drug testing policy.
This shift does not mean employers must abandon drug testing or accept impairment at work. It does mean that policies and testing tools need to be more precise. A good California workplace drug testing policy [R&A comment – any workplace drug testing policy] now starts with a clear understanding of what the employer is actually trying to measure and why. Is the goal to screen out high-risk substance use generally? To protect safety-sensitive roles? To investigate incidents? To comply with specific contractual obligations? Each of those goals may still be valid, but they may not all be served by the same test panel or the same approach to THC.
A positive result may tell an employer that a person used cannabis at some point in the recent past, but it says very little about whether that person is currently under the influence at work. In a state where off-duty cannabis use may be protected in many situations, relying on this kind of result for routine employment decisions can create risk instead of reducing it.
This is where panel design becomes important.
The shift toward these no-THC configurations is not about becoming lax on safety. In many ways, it reflects a more mature approach to risk. By focusing testing on substances that clearly undermine workplace safety and performance, and by not over-relying on marijuana metabolite results that may have limited relevance to on-the-job behavior, employers can build programs that are both more respectful of employee rights and more focused on true impairment risks. For many organizations, especially those outside of heavily regulated safety-sensitive roles, this approach makes day-to-day administration simpler and easier to explain.
Updating policy is the next step. A well-written California workplace drug testing policy [R&A Comment – and any workplace drug test policy] should spell out which positions are subject to testing, when testing will occur, and which types of tests are used in which situations. Pre-employment testing might rely on a no THC 5 panel urine cup or similar configuration, while post-incident or reasonable-suspicion testing could use broader tools or different specimen types. The key is to tie each testing decision to a clear business rationale. A forklift operator or machine technician in a busy warehouse may legitimately be held to a different standard than a purely remote office worker, and the policy should articulate those differences in a straightforward way.
Communication is just as important as drafting. Employees and applicants should be able to read the policy and understand, in plain language, what is expected of them. That includes a clear statement that the employer prohibits on-duty impairment and unsafe behavior, even in an era of legal cannabis. It also includes an explanation that the employer uses testing tools designed to be fair, current, and consistent with California’s approach to cannabis. When people understand that the organization has intentionally chosen, for example, a no THC urine drug test cup for certain roles to avoid punishing lawful off-duty behavior, they are more likely to see the program as legitimate rather than arbitrary.
Supervisors need training that goes beyond “send them for a test.” They should understand the difference between historical exposure and current impairment, and they should know how to document what they see. A strong policy will give them guidance on recognizing potential impairment signs, when to escalate, and how to handle a situation without making premature judgments. It will also explain how non-negative results are reviewed, including when confirmatory testing is used and when medical or human resources input is required before any employment action is taken.
The legal environment in California also encourages employers to segment their testing strategy. Not every situation calls for the same panel. Routine pre-employment screens for many roles may rely on no THC multi panel urine drug test products, while more specialized testing may still include THC in tightly defined circumstances, such as where another law requires it or where a job is clearly safety-sensitive and policy language has been carefully crafted around that reality.
From an occupational health perspective, this evolution is a positive one. It moves workplace drug testing closer to its original purpose: supporting safety, reliability, and fitness for duty.
Of course, updating a policy can feel daunting. Many organizations have used the same wording and panels for years, and there is understandable concern about “getting it wrong” in a changing legal environment. That is why a careful, step-by-step review is helpful. Start with your goals. Clarify which roles are safety-sensitive and why. Map your current practices to those goals. Identify where your existing panels and procedures still make sense—and where they might be out of step with modern cannabis rules. Then consider how tools like a no THC urine drug test cup, a no THC 5 panel urine cup, or another no THC multi panel urine drug test could support a more targeted approach.
Finally, remember that a policy update is not a one-time event. Laws, guidance, and workplace norms continue to evolve, and your program should be reviewed on a regular cycle. Periodic check-ins allow you to adjust panels, refine language, and update supervisor training as needed.
James P. Randisi, President of Randisi & Associates, Inc., has been helping employers protect their clients, workforce and reputation through implementation of employment screening and drug testing programs since 1999. This post does not constitute legal advice. Randisi & Associates, Inc. is not a law firm. Always contact competent employment legal counsel. To learn more about the rights of employees who test positive for marijuana, Mr. Randisi can be contacted by phone at 410.336.0287 or Email: info@randisiandassociates.com or the website at Randisiandassociates.com
